Physician profile
Rajeev Singh
NPI 1194169417
$15,756.51
in general payments reported to CMS, 2019-2025
36 companies · $7,669 in 2025
The $7,669 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $773 · 2020: $275 · 2021: $955 · 2022: $2,004 · 2023: $2,078 · 2024: $2,002 · 2025: $7,669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,444 · Consulting Fee: $5,000 · Travel and Lodging: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,443.97 |
| Consulting Fee | $5,000.00 |
| Travel and Lodging | $305.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,292.40 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Mitraclip |
| Novartis Pharmaceuticals Corporation | $1,521.62 | 2020-2025 | |
| Cvrx, INC. | $834.07 | 2021-2025 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $789.63 | 2020-2025 | Amvuttra, Onpattro |
| Merck Sharp & Dohme LLC | $747.68 | 2022-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals Lp | $710.26 | 2021-2025 | Wainua, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $672.69 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $665.88 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $586.23 | 2021-2025 | Jardiance |
| Bridgebio Pharma, INC. | $251.64 | 2025 | Attruby |
| Medtronic, INC. | $220.52 | 2021-2024 | Venaseal |
| Pfizer INC. | $201.96 | 2019-2025 | |
| Penumbra, INC. | $160.92 | 2023 | Indigo System |
| Boston Scientific Corporation | $139.87 | 2021-2024 | Varithena Administration Pack |
| Picard Medical INC. | $109.15 | 2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $104.05 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $67.90 | 2022-2024 | Optimizer |
| Scpharmaceuticals INC. | $66.60 | 2025 | |
| Novo Nordisk INC | $62.75 | 2024-2025 | Ozempic, Rybelsus |
| Daiichi Sankyo INC. | $62.19 | 2021-2023 | Injectafer |
| Kestra Medical Technology Services, INC. | $55.99 | 2022-2023 | Assure Wcd |
| Eurofins Viracor, LLC | $53.90 | 2023 | |
| Kiniksa Pharmaceuticals, Ltd. | $48.04 | 2022-2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $45.65 | 2021 | |
| Amgen INC. | $40.77 | 2023-2024 | Repatha |
| Lexicon Pharmaceuticals, INC. | $38.69 | 2023-2024 | Inpefa |
| La Jolla Pharmaceutical Company | $30.09 | 2022 | |
| Edwards Lifesciences Corporation | $26.77 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Genzyme Corporation | $22.45 | 2023 | |
| Atricure, INC. | $22.38 | 2025 | Synergy Ablation System |
| Phadia US INC. | $20.13 | 2022 | |
| Abiomed | $20.09 | 2023 | Impella |
| Lilly USA, LLC | $16.77 | 2025 | |
| Argon Medical Devices, INC. | $16.36 | 2025 | Clot Management |
| Nuwellis, INC. | $15.81 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $14.61 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajeev Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.